Quantification of Virus Infectivity: The Key Assay for the Development of Viral Therapeutics
Ramona Businger(Boehringer Ingelheim (Germany)), Johannes Solzin(Boehringer Ingelheim (Germany)), Dominik Hotter(Boehringer Ingelheim (Germany)), Daniel Hochdorfer(Boehringer Ingelheim (Germany))
Cited by 0
Related Papers
IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP
|Nature Communications|2017|290
Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity
|Cell Host & Microbe|2016|272
Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins
|Cell Reports|2019|195
IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation
|Cell Host & Microbe|2019|138